Adjuvant Capital Leads USD15m Series A for Nigerian Genomics Company 54gene

Source(s): 54gene

Adjuvant Capital, a health-focused investment firm backed by IFC and the Bill & Melinda Gates Foundation, led a USD15m Series A for Nigeria-based genomics company 54gene, with participation from Raba Capital, V8 Capital, and Ingressive Capital, and follow-on investments from Y Combinator, Better Ventures, Fifty Years, KdT Ventures, Aera VC, and Pioneer Fund. Read more